Medical Posters

RSS

Exploring the antiviral potential of sugar-coated nanostructures against influenza A and SARS-CoV-2

This article highlights the development of sugar-coated nanostructures as a novel approach to combat influenza A and SARS-CoV-2.

From Swansea University 6 Nov 2025

Exploring the combined antiproliferative effects of artesunate and resveratrol in Ishikawa endometrial cancer cells

Study finds enhanced antiproliferative activity in Ishikawa cells using combined artesunate and resveratrol treatment.

From Birmingham City University 6 Nov 2025

Stress response biomarkers and assays in motor neuron disease research

Learn how stress response assays help screen for compounds that enhance neuronal resilience, accelerating drug discovery for motor neuron disease.

From Life Arc 5 Nov 2025

Enhancing structural biology with microgravity-grown protein crystals

Discover how growing protein crystals in microgravity environments leads to higher-resolution structures and fewer defects.

From Frontier Space Technologies 5 Nov 2025

Advancing immunology research with CRISPR screening

This article highlights how VISTA technology enables robust CRISPR-based target discovery workflows in primary immune cells.

From Myllia Biotechnology GmbH 5 Nov 2025

Combining CRISPR gene editing and microfluidics for 3D target validation

Discover how CRISPR-on-chip technology integrates microfluidics and 3D cell culture to enable relevant target validation studies.

From Okomera 5 Nov 2025

Integrating multimodal datasets for advanced tertiary analysis

This article highlights how SONRAI BioDiscovery unifies diverse biological data streams to perform comprehensive, context-enriched tertiary analysis.

From Sonrai Analytics 5 Nov 2025

Redefining experimental workflows with epitope-specific recombinant reagents

Explore how epitope-defined recombinant reagents improve the accuracy of experimental assays, supporting next-generation biomedical research.

From Proteintech Group, Inc 5 Nov 2025

Accelerating hit discovery with SPACEM1: Generative deep models meet real-world validation

Discover how SPACEM1 integrates AI-driven generative deep models to transform virtual screening into validated hit discovery in weeks.

From Molecule One 5 Nov 2025

Discovery of potential therapeutic targets in schistosomula through dual systematic analysis

Explore how a dual systematic approach combining in-silico modeling and literature review led to the identification of schistosomula-derived targets.

From Kumasi Centre for Collaborative Research in Tropical Medicine (KCCR) 5 Nov 2025

Redefining target engagement with new strategies in drug discovery

Discover how next-generation target engagement assays are enhancing drug discovery by offering clearer insights into compound binding, selectivity, and mechanism of action.

From Selvita 4 Nov 2025

Investigating site-specific phospho-tau differences in Alzheimer’s disease

Understand the molecular differences that set Alzheimer’s disease (AD) apart from healthy brain tissue.

From BMG LABTECH GmbH 4 Nov 2025

Accelerating assay development through accessible benchtop automation

Discover how accessible benchtop automation enables faster, more efficient assay development.

From AstraZeneca 4 Nov 2025

Automating optical pooled screening with massively multiplexed phenotypic readouts

Discover how automation on the AVITI24 platform enables optical pooled screens with massively multiplexed phenotypic readouts.

From Element Biosciences 4 Nov 2025

High-throughput AI quantification of cardiomyocyte hypertrophy in rodent models

Discover how AI-powered image analysis enables high-throughput quantification of cardiomyocyte hypertrophy.

From AstraZeneca 4 Nov 2025

Improving virtual screening with a heterogeneous consensus model

Discover how a heterogeneous consensus model enhances interaction-based virtual screening.

From The University of Edinburgh 4 Nov 2025

Identifying coronavirus transcription inhibitors through phenotypic screening

Discover how phenotypic screening methods are used to identify compounds that inhibit coronavirus discontinuous transcription.

From IRBM 4 Nov 2025

Discovering SARS-CoV-2 NSP13 helicase inhibitors through integrated screening

Discover how a multi-stage screening cascade enables the identification of potent SARS-CoV-2 NSP13 helicase inhibitors.